Dizal's Sunvozertinib Pivotal Study Results Published in The Lancet Respiratory Medicine

/PRNewswire/ -- Dizal today announced that the results of a phase 2 pivotal study of sunvozertinib for the treatment of platinum-pretreated non-small-cell lung...

Related Keywords

Peking ,Beijing ,China ,Shanghai ,Chinese ,Mengzhao Wang ,Xiaolin Zhang ,Prnewswire Dizal ,Department Of Pulmonary Medicine ,National Medical Products Administration ,Business Development ,Department Of Thoracic Oncology ,Twitter ,Linkedin ,Lancet Respiratory Medicine ,Thoracic Oncology ,Cancer Hospital ,Chinese Academy ,Pulmonary Medicine ,Lung Cancer Center ,Peking Union Medical College Hospital ,Categoryi Innovative Drug ,Independent Review Committee ,Cancer Discovery ,Dizal Pharmaceutical ,Health Care Amp Hospitals ,Medical Pharmaceuticals ,Pharmaceuticals ,Biotechnology ,Clinical Trials Amp Medical Discoveries ,